Royce & Associates’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.99M	Buy	356,671 +78,483	+28%	+$2.57M	0.1%	328
2025 Q4	$10.4M	Buy	278,188 +196,430	+240%	+$6.46M	0.11%	288
2025 Q3	$2.25M	Buy	81,758 +259	+0.3%	+$8.92K	0.02%	579
2025 Q2	$2.58M	Sell	81,499 -260	-0.3%	-$8.36K	0.03%	564
2025 Q1	$2.71M	Hold	81,759	–	–	0.03%	546
2024 Q4	$2.81M	Buy	81,759 +3,056	+4%	+$105K	0.03%	576
2024 Q3	$3.15M	Sell	78,703 -11,413	-13%	-$401K	0.03%	557
2024 Q2	$2.72M	Sell	90,116 -8,122	-8%	-$244K	0.03%	582
2024 Q1	$3.3M	Sell	98,238 -11,365	-10%	-$365K	0.03%	564
2023 Q4	$3.54M	Sell	109,603 -170,746	-61%	-$4.77M	0.03%	564
2023 Q3	$9.19M	Buy	280,349 +60,770	+28%	+$2.11M	0.09%	317
2023 Q2	$7.73M	Sell	219,579 -112,750	-34%	-$3.89M	0.08%	383
2023 Q1	$10.9M	Buy	332,329 +102,059	+44%	+$4.65M	0.11%	284
2022 Q4	$12.7M	Sell	230,270 -65,740	-22%	-$3.61M	0.13%	228
2022 Q3	$13.1M	Buy	296,010 +27,813	+10%	+$1.36M	0.15%	199
2022 Q2	$13.1M	Buy	268,197 +12,390	+5%	+$558K	0.13%	222
2022 Q1	$12.4M	Buy	255,807 +36,723	+17%	+$1.5M	0.11%	290
2021 Q4	$9.34M	Sell	219,084 -10,306	-4%	-$411K	0.07%	410
2021 Q3	$8.79M	Buy	229,390 +101,340	+79%	+$3.26M	0.07%	457
2021 Q2	$3.62M	Buy	+128,050	New	+$3.84M	0.02%	665